Biomerica (BMRA) Other financing activities (2012 - 2025)

Biomerica (BMRA) posted Other financing activities of -$1000.0 for Q2 2025, down 150.0% sequentially from $2000.0 in Q2 2023.

Biomerica (BMRA) Other financing activities (2012 - 2025) Analysis & Trends

Biomerica has reported Other financing activities for 13 years, with the latest figure at -$1000.0 in Q2 2025.

Quarterly Other financing activities changed N/A year-over-year to -$1000.0 in Q2 2025, while the trailing twelve-month figure through May 2025 was $66000.0 (changed N/A YoY) and the FY2025 annual result came in at $15000.0, down 81.48% from the prior year.
Other financing activities slipped to -$1000.0 in Q2 2025 per BMRA's latest filing, from $2000.0 in the prior quarter.
Over five years, Other financing activities peaked at $65000.0 in Q4 2022 and troughed at -$1000.0 in Q2 2025.
A 4-year average of $20992.5 and a median of $9900.0 in 2021 frame the typical range for Other financing activities.
The sharpest annual moves came in 2021 and 2022: Other financing activities tumbled 95.96% in 2021, then soared 552.16% in 2022.
Over 4 years, Other financing activities stood at $30585.0 in 2021, then surged by 112.52% to $65000.0 in 2022, then sank by 96.92% to $2000.0 in 2023, then slumped by 150.0% to -$1000.0 in 2025.
According to Business Quant data, Other financing activities over the past three periods registered -$1000.0, $2000.0, and $65000.0 for Q2 2025, Q2 2023, and Q4 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Biomerica	4.85 Mn	3.51 Mn	-44,000.00

Download Data